EPO and triple-A syndrome: Altogether, these results indicated that low‐ and medium‐dose formoterol treatment alleviated apoptosis of VSMCs in the aortic tissues induced by EPO while high‐dose formoterol abolished the protective effect of formoterol on EPO‐induced AAA.